Bullish theses highlight several companies poised for growth: Travere Therapeutics (TVTX) and Ultragenyx (RARE) are biotech firms with key drug catalysts in 2026. Datadog (DDOG) and NetApp (NTAP) are software infrastructure leaders with strong market positions. DraftKings (DKNG) is seen as a dominant digital gaming platform, while Ambarella (AMBA) and Xometry (XMTR) are leveraging AI for growth in semiconductors and manufacturing.
Comments